Drug firm GlaxoSmithKline Pharmaceuticals today reported a 31.83 per cent rise in standalone net profit to Rs 130.32 crore for the second quarter ended September 30, 2017.
The company had posted a net profit of Rs 98.85 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.
The standalone total income of the company also rose to Rs 845.87 crore for the quarter under consideration as against Rs 817.20 crore in the same period a year ago.
Shares of GlaxoSmithKline Pharmaceuticals today closed at at Rs 2,422.80 per scrip on BSE, down 0.99 per cent from its previous close.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.